Skip to main content
Erschienen in: Inflammation 2/2010

01.04.2010

Characterization of ERK Activation in Human Mast Cells Stimulated by Contact with T Cells

verfasst von: Adam Mor, Irit Shefler, Pazit Salamon, Yoel Kloog, Yoseph A. Mekori

Erschienen in: Inflammation | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Close physical proximity between mast cells and T cells has been demonstrated in several human conditions. We have identified and characterized a novel mast cell activation pathway initiated by contact with T cells, and showed that this pathway is associated with cytokine release. It has been shown recently that Ras is activated in this pathway. Thus, in the present study we further explore the downstream events associated with Ras activation and cytokine release in human mast cells stimulated by contact with T cells. ERK activation in human mast cells stimulated by either contact with T cells or by crosslinking the FC epsilon receptor was studied. Photobleaching experiments were used to study ERK localization. Enzyme linked immunosorbent assay was used to study the cytokine release by human mast cells. We show that stimulation of human mast cells by contact with activated T cells results is sustained ERK activation. Furthermore, sustained ERK activation in these cells is associated with increased dwell time at the nucleus and with IL-8 release. Interestingly, when mast cells were stimulated by crosslinking the FC epsilon receptor I, ERK activation was transient. ERK activation was associated with a shorter dwell time at the nucleus and with TNF-α release. Thus, retaining ERK in the nucleus might be a mechanism utilized by human mast cells to generate different cytokines from a single signaling cascade.
Literatur
1.
Zurück zum Zitat Mekori, Y.A. 2004. The mastocyte: the “other” inflammatory cell in immunopathogenesis. Journal of Allergy and Clinical Immunology 114: 52–57.CrossRefPubMed Mekori, Y.A. 2004. The mastocyte: the “other” inflammatory cell in immunopathogenesis. Journal of Allergy and Clinical Immunology 114: 52–57.CrossRefPubMed
2.
Zurück zum Zitat Salamon, P., N.G. Shoham, R. Gavrieli, B. Wolach, and Y.A. Mekori. 2005. Human mast cells release Interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy 60: 1316–1319.CrossRefPubMed Salamon, P., N.G. Shoham, R. Gavrieli, B. Wolach, and Y.A. Mekori. 2005. Human mast cells release Interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy 60: 1316–1319.CrossRefPubMed
3.
Zurück zum Zitat Mekori, Y.A., and D.D. Metcalfe. 1999. Mast cell-T cell interactions. Journal of Allergy and Clinical Immunology 104: 517–523.CrossRefPubMed Mekori, Y.A., and D.D. Metcalfe. 1999. Mast cell-T cell interactions. Journal of Allergy and Clinical Immunology 104: 517–523.CrossRefPubMed
4.
Zurück zum Zitat Shefler, I., Y.A. Mekori, and A. Mor. 2008. Stimulation of human mast cells by activated T cells leads to N-Ras activation through Ras guanine nucleotide releasing protein 1. Journal of Allergy and Clinical Immunology 122: 1222–1225.CrossRefPubMed Shefler, I., Y.A. Mekori, and A. Mor. 2008. Stimulation of human mast cells by activated T cells leads to N-Ras activation through Ras guanine nucleotide releasing protein 1. Journal of Allergy and Clinical Immunology 122: 1222–1225.CrossRefPubMed
5.
Zurück zum Zitat Baram, D., G.G. Vaday, P. Salamon, I. Drucker, R. Hershkoviz, and Y.A. Mekori. 2001. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-&#x03B1. Journal of Immunology 167: 4008–4016. Baram, D., G.G. Vaday, P. Salamon, I. Drucker, R. Hershkoviz, and Y.A. Mekori. 2001. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-&#x03B1. Journal of Immunology 167: 4008–4016.
6.
Zurück zum Zitat Salamon, P., N.G. Shoham, I. Puxeddu, Y. Paitan, F. Levi-Schaffer, and Y.A. Mekori. 2008. Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance. Journal of Allergy and Clinical Immunology 121: 488–55.CrossRef Salamon, P., N.G. Shoham, I. Puxeddu, Y. Paitan, F. Levi-Schaffer, and Y.A. Mekori. 2008. Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance. Journal of Allergy and Clinical Immunology 121: 488–55.CrossRef
7.
Zurück zum Zitat Shaul, Y.D., and R. Seger. 2007. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochimica et Biophysica Acta 1773: 1213–1226.PubMed Shaul, Y.D., and R. Seger. 2007. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochimica et Biophysica Acta 1773: 1213–1226.PubMed
8.
Zurück zum Zitat Furuno, T., and M. Nakanishi. 2005. Live cell imaging to study signaling molecules in allergic reactions. Biological and Pharmaceutical Bulletin 28: 1551–1559.CrossRefPubMed Furuno, T., and M. Nakanishi. 2005. Live cell imaging to study signaling molecules in allergic reactions. Biological and Pharmaceutical Bulletin 28: 1551–1559.CrossRefPubMed
9.
Zurück zum Zitat Furuno, T., N. Hirashima, S. Onizawa, N. Sagiya, and M. Nakanishi. 2001. Nuclear shuttling of mitogen-activated protein (MAP) kinase (Extracellular signal-regulated Kinase (ERK) 2) was dynamically controlled by MAP/ERK kinase after antigen stimulation in RBL-2H3 cells. Journal of Immunology 166: 4416–4421. Furuno, T., N. Hirashima, S. Onizawa, N. Sagiya, and M. Nakanishi. 2001. Nuclear shuttling of mitogen-activated protein (MAP) kinase (Extracellular signal-regulated Kinase (ERK) 2) was dynamically controlled by MAP/ERK kinase after antigen stimulation in RBL-2H3 cells. Journal of Immunology 166: 4416–4421.
10.
Zurück zum Zitat Goodwin, J.S., and A.K. Kenworthy. 2005. Photobleaching approaches to investigate diffusional mobility and trafficking of Ras in living cells. Methods 37: 154–164.CrossRefPubMed Goodwin, J.S., and A.K. Kenworthy. 2005. Photobleaching approaches to investigate diffusional mobility and trafficking of Ras in living cells. Methods 37: 154–164.CrossRefPubMed
11.
Zurück zum Zitat Olenchock, B.A., R. Guo, M.A. Silverman, J.N. Wu, J.H. Carpenter, G.A. Koretzky, and X.P. Zhong. 2006. Impaired degranulation but enhanced cytokine production after FcεRI stimulation of diacylglycerol kinase ζ–defi cient mast cells. Journal of Experimental Medicine 203: 1471–1480.CrossRefPubMed Olenchock, B.A., R. Guo, M.A. Silverman, J.N. Wu, J.H. Carpenter, G.A. Koretzky, and X.P. Zhong. 2006. Impaired degranulation but enhanced cytokine production after FcεRI stimulation of diacylglycerol kinase ζ–defi cient mast cells. Journal of Experimental Medicine 203: 1471–1480.CrossRefPubMed
12.
Zurück zum Zitat Kashyap, M., A.M. Thornton, S.K. Norton, B. Barnstein, M. Macey, J. Brenzovich, E. Shevach, W.J. Leonard, and J.J. Ryan. 2008. CD4 T Cell-Mast cell interactions alter IgE receptor expression and signaling. Journal of Immunology 180: 2039–2043. Kashyap, M., A.M. Thornton, S.K. Norton, B. Barnstein, M. Macey, J. Brenzovich, E. Shevach, W.J. Leonard, and J.J. Ryan. 2008. CD4 T Cell-Mast cell interactions alter IgE receptor expression and signaling. Journal of Immunology 180: 2039–2043.
13.
Zurück zum Zitat Hundley, T.R., A.M. Gilfillan, C. Tkaczyk, M.V. Andrade, D.D. Metcalfe, and M.A. Beaven. 2004. Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104: 2410–2417.CrossRefPubMed Hundley, T.R., A.M. Gilfillan, C. Tkaczyk, M.V. Andrade, D.D. Metcalfe, and M.A. Beaven. 2004. Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104: 2410–2417.CrossRefPubMed
14.
Zurück zum Zitat Kambayashi, T., and G.A. Koretzky. 2007. Proximal signaling events in FceRI-mediated mast cell activation. Journal of Allergy and Clinical Immunology 119: 544–552.CrossRefPubMed Kambayashi, T., and G.A. Koretzky. 2007. Proximal signaling events in FceRI-mediated mast cell activation. Journal of Allergy and Clinical Immunology 119: 544–552.CrossRefPubMed
15.
Zurück zum Zitat Mansour, S.J., W.T. Matten, A.S. Hermann, J.M. Candia, S. Rong, K. Fukasawa, G.F. Wounde-Vande, and N.G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966–970.CrossRefPubMed Mansour, S.J., W.T. Matten, A.S. Hermann, J.M. Candia, S. Rong, K. Fukasawa, G.F. Wounde-Vande, and N.G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966–970.CrossRefPubMed
16.
Zurück zum Zitat Werlen, G., B. Hausmann, and E. Palmer. 2000. A motif in the alpha beta T-cell receptor controls positive selection by modulating ERK activity. Nature 406: 422–426.CrossRefPubMed Werlen, G., B. Hausmann, and E. Palmer. 2000. A motif in the alpha beta T-cell receptor controls positive selection by modulating ERK activity. Nature 406: 422–426.CrossRefPubMed
17.
Zurück zum Zitat Daniels, M.A., E. Teixeiro, J. Gill, B. Hausmann, D. Roubaty, K. Holmberg, G. Werlen, G.A. Hollander, N.R. Gascoigne, and E. Palmer. 2006. Thymic selection threshold defined by compartmentalization of Ras/MAPK signaling. Nature 444: 724–729.CrossRefPubMed Daniels, M.A., E. Teixeiro, J. Gill, B. Hausmann, D. Roubaty, K. Holmberg, G. Werlen, G.A. Hollander, N.R. Gascoigne, and E. Palmer. 2006. Thymic selection threshold defined by compartmentalization of Ras/MAPK signaling. Nature 444: 724–729.CrossRefPubMed
18.
Zurück zum Zitat Barrett, D.D., and D. Barlocco. 2001. Monitor: molecules and profiles. Drug Discovery Today 6: 437–438.CrossRefPubMed Barrett, D.D., and D. Barlocco. 2001. Monitor: molecules and profiles. Drug Discovery Today 6: 437–438.CrossRefPubMed
19.
Zurück zum Zitat Finlay, G.A., V.J. Thannickal, B.L. Fanburg, and K.E. Paulson. 2000. Transforming growth factor-β1-induced activation of the ERK Pathway/AP-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. Journal of Biological Chemistry 275: 27650–27656.PubMed Finlay, G.A., V.J. Thannickal, B.L. Fanburg, and K.E. Paulson. 2000. Transforming growth factor-β1-induced activation of the ERK Pathway/AP-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. Journal of Biological Chemistry 275: 27650–27656.PubMed
20.
Zurück zum Zitat Sasagawa, S., Y. Ozaki, K. Fujita, and S. Kuroda. 2005. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nature Cell Biology 7: 365–373.CrossRefPubMed Sasagawa, S., Y. Ozaki, K. Fujita, and S. Kuroda. 2005. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nature Cell Biology 7: 365–373.CrossRefPubMed
21.
Zurück zum Zitat Jaaro, H., H. Rubinfiekd, T. Hanoch, and R. Seger. 1997. Nuclear translocation of mitogen-activated protein kinase (MEK1) in response to mitogenic stimulation. Proceedings of the National Academy of Science 94: 3742–3747.CrossRef Jaaro, H., H. Rubinfiekd, T. Hanoch, and R. Seger. 1997. Nuclear translocation of mitogen-activated protein kinase (MEK1) in response to mitogenic stimulation. Proceedings of the National Academy of Science 94: 3742–3747.CrossRef
22.
Zurück zum Zitat Chuderland, D., A. Konson, and R. Seger. 2008. Identification and characterization of a general nuclear translocation signal proteins. Molecular Cell 31: 850–861.CrossRefPubMed Chuderland, D., A. Konson, and R. Seger. 2008. Identification and characterization of a general nuclear translocation signal proteins. Molecular Cell 31: 850–861.CrossRefPubMed
Metadaten
Titel
Characterization of ERK Activation in Human Mast Cells Stimulated by Contact with T Cells
verfasst von
Adam Mor
Irit Shefler
Pazit Salamon
Yoel Kloog
Yoseph A. Mekori
Publikationsdatum
01.04.2010
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2010
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-009-9165-8

Weitere Artikel der Ausgabe 2/2010

Inflammation 2/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.